))
Additional Insights in Dedifferentiated Liposarcoma With Richard F. Riedel, MD, and Candace L. Haddox, MD
Manage episode 495977881 series 3456244
Content provided by i3 Health and I3 Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by i3 Health and I3 Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
As research in dedifferentiated liposarcoma (DDLPS) continues to advance, the importance of multidisciplinary collaboration and access to innovative therapies remains at the forefront of patient care. Recently, Dr. Richard Riedel of Duke Cancer Institute and Dr. Candace Haddox of Dana-Farber Cancer Institute co-chaired i3 Health’s DDLPS Task Force activity, which brought together a panel of experts to address the complexities of this rare and challenging sarcoma subtype. With new clinical trials underway and a growing understanding of the disease’s molecular landscape, Dr. Riedel and Dr. Haddox sat down to highlight promising research directions and insights in honor of Sarcoma Awareness Month in July. After listening to the interview, stay tuned to hear the full accredited podcast with Dr. Riedel and Dr. Haddox, and click the link below to claim free CME/AAPA credit. Click the links below for the Task Force activity! - Accredited CME/AAPA Podcast: https://i3health.com/course-information/podcast-ddlps - Position Statement Published in Cancer Treatment Reviews: https://www.cancertreatmentreviews.com/article/S0305-7372(24)00175-0/fulltext - Live Task Force Recording: https://youtu.be/Otr5_tiFQ68
…
continue reading
77 episodes
Share
